Medicine and Dentistry
Patient
100%
Classical Hodgkin Lymphoma
60%
Adult
60%
Acute B-Cell Lymphoblastic Leukemia
60%
Therapeutic Procedure
38%
Outpatient
37%
Chimeric Antigen Receptor T-Cell Immunotherapy
32%
Hematology
32%
Donor
32%
Rituximab
30%
Gemcitabine
30%
Pediatrics
30%
Retrospective Study
30%
Drug Megadose
30%
Lymphoproliferative Disease
30%
Oxaliplatin
30%
Transplantation
30%
Diabetes
30%
Hyperglycemia
30%
Myelodysplastic Syndrome
30%
Aplastic Anemia
30%
Paroxysmal Nocturnal Hemoglobinuria
30%
Chemotherapy
16%
Toxicity
15%
Oncology
13%
Spontaneous Remission
11%
Disease
11%
Overall Survival
10%
Stem Cell Transplant
10%
Child
9%
Hodgkin's Lymphoma
8%
Adolescence
8%
Immunosuppressive Treatment
8%
High Risk Population
7%
Inpatient
7%
Platinum
7%
Febrile Neutropenia
7%
Follow up
6%
Chimeric Antigen Receptor T-Cell
5%
Maturity Onset Diabetes of the Young
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
30%
Antileukemic Agent
28%
Chemotherapy
20%
Doxorubicin
20%
Etoposide
10%
Ifosfamide
10%
Graft Versus Host Reaction
9%
Neurotoxicity
5%
Clinical Trial
5%
Leukemia
5%
